Carnegie Lake Advisors’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$746K Hold
154,745
0.28% 82
2026
Q1
$953K Sell
154,745
-7,100
-4% -$59K 0.38% 71
2025
Q4
$1.69M Sell
161,845
-32,500
-17% -$326K 0.64% 36
2025
Q3
$1.75M Buy
194,345
+87,345
+82% +$767K 0.67% 36
2025
Q2
$1.39M Buy
+107,000
New +$1.61M 0.55% 50

Other funds holding RXST

Carnegie Lake Advisors's RXST Position: Q2 2026 in Review

Carnegie Lake Advisors held its RxSight (RXST) position steady in Q2 2026 at 154,745 shares worth $746K. The position accounts for 0.28% of the portfolio, ranked #82.

Carnegie Lake Advisors first reported a position in RXST in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.75M in Q3 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Carnegie Lake Advisors held 154,745 shares of RxSight worth $746K as of Q2 2026.
  • Carnegie Lake Advisors left its RxSight share count unchanged in Q2 2026.
  • RxSight made up 0.28% of Carnegie Lake Advisors's portfolio in Q2 2026, its #82 holding.
  • Carnegie Lake Advisors first reported a position in RxSight in Q2 2025 and has held it in 5 quarters since.
  • Carnegie Lake Advisors's RxSight position peaked at $1.75M in Q3 2025.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Carnegie Lake Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.